Income statement, balance sheet and cash flow statement for the last 1 fiscal years, taken from the XBRL data Ping An Biomedical Co., Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2025
Revenue
4.8
Cost of revenue
4.66
Gross profit
0.13
Selling and marketing
0.04
General and administrative
0.84
Operating expenses
2.2
Operating income
-2.07
Interest expense
0.04
Interest income
0.05
Other non-operating income
0
Pre-tax income
-2.06
Income tax
0.26
Net income
-1.8
EBITDA
-2.06
EPS, basic
-0.10
EPS, diluted
-0.10
Shares, basic (weighted)
18.5
Shares, diluted (weighted)
18.5
Balance sheet
FY2025
Cash and equivalents
0.16
Receivables
2.38
Inventory
0.06
Other current assets
1.35
Total current assets
8.95
Lease right-of-use assets
0.07
Total assets
9.61
Accounts payable
1.32
Deferred revenue
0.01
Short-term debt
1.4
Total current liabilities
3.24
Lease liabilities
0.01
Total liabilities
3.26
Paid-in capital
9.3
Retained earnings
-2.96
Other comprehensive income
-0.23
Shareholders' equity
6.36
Total equity
6.36
Total liabilities and equity
9.61
Shares outstanding
20.5
Cash flow statement
FY2025
Net income
-1.8
Depreciation and amortization
0
Change in receivables
1.99
Change in inventory
-0.04
Change in payables
-0.79
Cash from operations
-0.9
Cash from financing
6.13
Exchange rate effect
-0.09
Net change in cash
5.23
Interest paid
0.04
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.13 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
2.8%
Gross profit / revenue.
Operating margin
-43.1%
Operating income / revenue.
EBITDA margin
-43.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-43.0%
Pre-tax income / revenue.
Net margin
-37.6%
Net income / revenue.
Operating cash flow margin
-18.8%
Cash from operations / revenue.
Return on equity (ROE)
-28.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-18.8%
Net income / average total assets.
Return on invested capital (ROIC)
-26.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
D&A / revenue
0.0%
Depreciation and amortization / revenue.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.76x
Current assets / current liabilities.
Quick ratio
0.78x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.05x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.10
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.10
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.26
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.05
Cash from operations / diluted weighted shares.
Book value per share
$0.31
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
3.30x
Market cap / revenue.
P/B
2.49x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.49x
Market cap / tangible book value, when positive.
EV/Sales
3.26x
Enterprise value / revenue.
Earnings yield
-11.4%
Net income / market cap (the inverse of P/E).
What was Ping An Biomedical Co., Ltd.'s revenue in fiscal 2025?
Ping An Biomedical Co., Ltd. reported revenue of $4.8M for fiscal 2025.
Was Ping An Biomedical Co., Ltd. profitable in fiscal 2025?
No. It reported a net loss of $1.8M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.